Cuu Long Pharmaceutical Share Price

Equities

DCL

VN000000DCL1

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
27,300 VND 0.00% Intraday chart for Cuu Long Pharmaceutical +5.00% +9.20%

Financials

Sales 2022 1,016B 39.61M 3.34B Sales 2023 1,144B 44.61M 3.77B Capitalization 1,826B 71.22M 6.01B
Net income 2022 112B 4.35M 368M Net income 2023 61.72B 2.41M 203M EV / Sales 2022 2.11 x
Net Debt 2022 352B 13.73M 1.16B Net Debt 2023 512B 19.98M 1.69B EV / Sales 2023 2.04 x
P/E ratio 2022
15.4 x
P/E ratio 2023
29.6 x
Employees 930
Yield 2022 *
-
Yield 2023
-
Free-Float 41.95%
More Fundamentals * Assessed data
Dynamic Chart
Cuu Long Pharmaceutical Joint Stock Company Announces Management Resignations CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Announces Change in Personnel CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Announces the Resignation of Nghiem Xuan Truong as CFO CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Luong Trong Hai as Director CI
Cuu Long Pharmaceutical Joint Stock Company Announces CEO Changes CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Nguyen Ngoc Vinh as Deputy CEO CI
More news
1 week+5.00%
Current month+13.28%
1 month+13.28%
3 months+10.30%
6 months+21.60%
Current year+9.20%
More quotes
1 week
25 300.00
Extreme 25300
27 450.00
1 month
23 250.00
Extreme 23250
29 300.00
Current year
23 200.00
Extreme 23200
29 300.00
1 year
21 700.00
Extreme 21700
29 300.00
3 years
21 700.00
Extreme 21700
53 600.00
5 years
16 000.00
Extreme 16000
53 600.00
10 years
7 428.57
Extreme 7428.5714
53 600.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 18/21/18
Chairman 48 19/14/19
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member 53 -
Chairman 48 19/14/19
Director/Board Member - -
More insiders
Date Price Change Volume
26/24/26 27,300 0.00% 210,100
25/24/25 27,300 +0.18% 296,300
24/24/24 27,250 +4.81% 250,000
23/24/23 26,000 +0.39% 330,600
22/24/22 25,900 -0.38% 436,600

End-of-day quote Ho Chi Minh S.E., April 26, 2024

More quotes
Cuu Long Pharmaceutical Joint Stock Corporation (Pharimexco) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. It is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.
More about the company